Don't want ads? Subscribe or login now.

Aurinia Sues Lotus Alleging Lupus Drug Patent Infringement

By Adam Lidgett · April 11, 2025, 7:27 PM EDT

Kidney-focused biotech Aurinia Pharmaceuticals Inc. on Friday launched a lawsuit in New Jersey federal court claiming that Lotus Pharmaceutical Co. Ltd.'s bid to sell a generic form of Aurinia's lupus nephritis...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Complaint

Case Information

Case Title

AURINIA PHARMACEUTICALS INC. v. LOTUS PHARMACEUTICAL CO., LTD.

Case Number

2:25-cv-02613

Court

New Jersey

Nature of Suit

Patent - Abbreviated New Drug Application(ANDA)

Date Filed

April 11, 2025

Recent Articles By Adam

October 23, 2025
RingConn Settles With Oura After ITC Import Ban
October 21, 2025
Judge Trims Pharma Co. Claims Against Ex-Employees
October 21, 2025
Regeneron, Rival End Patent Fight Over Eye Med Biosimilar
September 30, 2025
Nevada Hospital Nets $510M Verdict In Staff Poaching Suit
September 29, 2025
House GOP Lawmakers Back ITC Import Ban Won By Oura
September 24, 2025
NY Appeals Court Backs Drug Co.'s $6.5M Contract Case Win
September 12, 2025
Jury Awards Mallinckrodt $9.5M In Nitric Oxide Patent Suit
September 08, 2025
Oura Domestic Labor Investment Won Import Ban, ITC Says
September 02, 2025
Gilead Rival Agrees Not To Sell Generic HIV Drug For Now
August 25, 2025
Oura Gets ITC To Bar Infringing Smart Ring Imports